48 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
2000 (the “FSMA”).
(oo) Anti-Corruption Laws. None of the Company, its Subsidiaries or to the knowledge of the Company, any director, officer, agent … 2010, or any other applicable anti-bribery or anti-corruption law; and (iv) made, offered, authorized, requested, or taken an act in furtherance of any
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
before and after grant of the MA, manufacturing of pharmaceutical products, statutory health insurance, bribery and anti-corruption or with other … with the requirements of these laws could adversely affect our financial condition.
Due to our international operations, we are subject to anti-corruption laws
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
the FD&C Act or becoming an article that may not, under the FD&C Act, be introduced into interstate commerce); and
(f)Anti-Bribery and Anti-Corruption Compliance … are required to comply with all Applicable Law, including applicable local and international anti-bribery and anti-corruption laws and regulations
S-8
EX-5.1
xc0 p8xov
13 Jan 22
Registration of securities for employees
4:31pm
F-3/A
EX-5.1
768q5
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
EX-5.1
01hkp6v6kgi mus66
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
v9m83t32h sl116tu4mz
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-5.1
7x1wu
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
S-8
EX-5.1
d3ioo3hujlwbcniw
15 Jan 21
Registration of securities for employees
4:21pm